Phase 2 trial with imeglimin in patients with Type 2 diabetes indicates effects on insulin secretion and sensitivity

Theurey, P; Thang, C; Pirags, V; Mari, A; Pacini, G; Bolze, S; Hallakou-Bozec, S; Fouqueray, P

Theurey, P (通讯作者)，Poxel SA, Lyon, France.

ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (6):

Abstract

Introduction The aim of the present study was to evaluate the effect of 18-week monotherapy with imeglimin on glucose tolerance and on insulin secreti......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索